146 related articles for article (PubMed ID: 7944142)
1. Selection of Pseudomonas exotoxin-resistant cells with altered expression of alpha 2MR/LRP.
Fitzgerald DJ; Fryling CM; Zdanovsky A; Saelinger CB; Kounnas M; Strickland DK; Leppla S
Ann N Y Acad Sci; 1994 Sep; 737():138-44. PubMed ID: 7944142
[No Abstract] [Full Text] [Related]
2. Pseudomonas exotoxin-mediated selection yields cells with altered expression of low-density lipoprotein receptor-related protein.
FitzGerald DJ; Fryling CM; Zdanovsky A; Saelinger CB; Kounnas M; Winkles JA; Strickland D; Leppla S
J Cell Biol; 1995 Jun; 129(6):1533-41. PubMed ID: 7790352
[TBL] [Abstract][Full Text] [Related]
3. Functional expression of the chicken low density lipoprotein receptor-related protein in a mutant chinese hamster ovary cell line restores toxicity of Pseudomonas exotoxin A and degradation of alpha2-macroglobulin.
Avramoglu RK; Nimpf J; McLeod RS; Ko KW; Wang Y; FitzGerald D; Yao Z
J Biol Chem; 1998 Mar; 273(11):6057-65. PubMed ID: 9497322
[TBL] [Abstract][Full Text] [Related]
4. Genetic deficiency in low density lipoprotein receptor-related protein confers cellular resistance to Pseudomonas exotoxin A. Evidence that this protein is required for uptake and degradation of multiple ligands.
Willnow TE; Herz J
J Cell Sci; 1994 Mar; 107 ( Pt 3)():719-26. PubMed ID: 8006085
[TBL] [Abstract][Full Text] [Related]
5. Ligand-toxin hybrids directed to the alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein exhibit lower toxicity than native Pseudomonas exotoxin.
Zdanovsky AG; Zdanovskaia MV; Strickland D; FitzGerald DJ
J Biol Chem; 1996 Mar; 271(11):6122-8. PubMed ID: 8626399
[TBL] [Abstract][Full Text] [Related]
6. Fusions of anthrax toxin lethal factor to the ADP-ribosylation domain of Pseudomonas exotoxin A are potent cytotoxins which are translocated to the cytosol of mammalian cells.
Arora N; Klimpel KR; Singh Y; Leppla SH
J Biol Chem; 1992 Aug; 267(22):15542-8. PubMed ID: 1639793
[TBL] [Abstract][Full Text] [Related]
7. Level of receptor-associated protein moderates cellular susceptibility to pseudomonas exotoxin A.
Mucci D; Forristal J; Strickland D; Morris R; Fitzgerald D; Saelinger CB
Infect Immun; 1995 Aug; 63(8):2912-8. PubMed ID: 7622212
[TBL] [Abstract][Full Text] [Related]
8. Decreased expression and function of alpha-2 macroglobulin receptor/low density lipoprotein receptor-related protein in photodynamic therapy-resistant mouse tumor cells.
Luna MC; Ferrario A; Rucker N; Gomer CJ
Cancer Res; 1995 May; 55(9):1820-3. PubMed ID: 7728745
[TBL] [Abstract][Full Text] [Related]
9. Mutations in the elongation factor 2 gene which confer resistance to diphtheria toxin and Pseudomonas exotoxin A. Genetic and biochemical analyses.
Foley BT; Moehring JM; Moehring TJ
J Biol Chem; 1995 Sep; 270(39):23218-25. PubMed ID: 7559470
[TBL] [Abstract][Full Text] [Related]
10. A mutant CHO-K1 strain with resistance to Pseudomonas exotoxin A is unable to process the precursor fusion glycoprotein of Newcastle disease virus.
Inocencio NM; Moehring JM; Moehring TJ
J Virol; 1993 Jan; 67(1):593-5. PubMed ID: 8416387
[TBL] [Abstract][Full Text] [Related]
11. Divergent Pseudomonas exotoxin A sensitivity in normal and transformed liver cells is correlated with low-density lipoprotein receptor-related protein expression.
Laithwaite JE; Benn SJ; Marshall WS; FitzGerald DJ; LaMarre J
Toxicon; 2001 Sep; 39(9):1283-90. PubMed ID: 11384715
[TBL] [Abstract][Full Text] [Related]
12. Targeted inhibition of tumor-cell growth by recombinant heregulin-toxin fusion proteins.
Jeschke M; Wels W; Dengler W; Imber R; Stöcklin E; Groner B
Int J Cancer; 1995 Mar; 60(5):730-9. PubMed ID: 7860149
[TBL] [Abstract][Full Text] [Related]
13. Enhanced macrophage resistance to Pseudomonas exotoxin A is correlated with decreased expression of the low-density lipoprotein receptor-related protein.
Laithwaite JE; Benn SJ; Yamate J; FitzGerald DJ; LaMarre J
Infect Immun; 1999 Nov; 67(11):5827-33. PubMed ID: 10531236
[TBL] [Abstract][Full Text] [Related]
14. Low density lipoprotein receptor-related protein (LRP) expression varies among Hep G2 cell lines.
Grimsley PG; Quinn KA; Chesterman CN; Owensby DA
Thromb Res; 1997 Dec; 88(6):485-98. PubMed ID: 9610960
[TBL] [Abstract][Full Text] [Related]
15. Selective killing of IL6 receptor bearing myeloma cells using recombinant IL6-Pseudomonas toxin.
Siegall CB; FitzGerald DJ; Pastan I
Curr Top Microbiol Immunol; 1990; 166():63-9. PubMed ID: 2127396
[No Abstract] [Full Text] [Related]
16. Pseudomonas exotoxin and recombinant immunotoxins derived from it.
Fitzgerald D; Pastan I
Ann N Y Acad Sci; 1993 Jun; 685():740-5. PubMed ID: 8363279
[TBL] [Abstract][Full Text] [Related]
17. Use of exotoxin A to inhibit protein synthesis.
Saelinger CB
Methods Enzymol; 1988; 165():226-31. PubMed ID: 3148096
[No Abstract] [Full Text] [Related]
18. A recombinant form of Pseudomonas exotoxin directed at the epidermal growth factor receptor that is cytotoxic without requiring proteolytic processing.
Theuer CP; FitzGerald D; Pastan I
J Biol Chem; 1992 Aug; 267(24):16872-7. PubMed ID: 1512230
[TBL] [Abstract][Full Text] [Related]
19. Targeting of interleukin-13 receptor on human renal cell carcinoma cells by a recombinant chimeric protein composed of interleukin-13 and a truncated form of Pseudomonas exotoxin A (PE38QQR).
Puri RK; Leland P; Obiri NI; Husain SR; Kreitman RJ; Haas GP; Pastan I; Debinski W
Blood; 1996 May; 87(10):4333-9. PubMed ID: 8639793
[TBL] [Abstract][Full Text] [Related]
20. Cytotoxic activity of an interleukin 6-Pseudomonas exotoxin fusion protein on human myeloma cells.
Siegall CB; Chaudhary VK; FitzGerald DJ; Pastan I
Proc Natl Acad Sci U S A; 1988 Dec; 85(24):9738-42. PubMed ID: 3264406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
